U.S. stock futures bounced back Tuesday morning as investors look ahead to a more earnings reports and a fresh read on weekly jobless claims out of Washington.
France will unveil a timetable for easing COVID-19 restrictions later on Thursday, government spokesman Gabriel Attal said, though he cautioned the wave of Omicron infections tearing through the country had not reached its peak. Attal said France's new vaccine pass rules would help allow a softening of rules even as the incidence rate of infections continues to increase. France reported nearly half a million coronavirus infections on Wednesday to leave the seven-day average at 320,000 cases.
WALTHAM, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies for people living with cancer, today announced that the first patient has been dosed in the company’s Phase 1/2 clinical trial evaluating XTX202 for the treatment of solid tumors. XTX202 is a modified form of IL-2 that is designed to localize activity in the tumor microenvironment (TME), with the goal of overcoming the known tolera